DE60104825D1 - Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen - Google Patents
Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungenInfo
- Publication number
- DE60104825D1 DE60104825D1 DE60104825T DE60104825T DE60104825D1 DE 60104825 D1 DE60104825 D1 DE 60104825D1 DE 60104825 T DE60104825 T DE 60104825T DE 60104825 T DE60104825 T DE 60104825T DE 60104825 D1 DE60104825 D1 DE 60104825D1
- Authority
- DE
- Germany
- Prior art keywords
- producing
- substituted
- intermediate compounds
- nicotine derivatives
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical class CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 125000001477 organic nitrogen group Chemical group 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000933A SE0000933D0 (sv) | 2000-03-21 | 2000-03-21 | Method of producing 6-substituted (S)-nicotine derivatives and intermediate compounds |
SE0000933 | 2000-03-21 | ||
PCT/SE2001/000599 WO2001070730A1 (en) | 2000-03-21 | 2001-03-21 | Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60104825D1 true DE60104825D1 (de) | 2004-09-16 |
DE60104825T2 DE60104825T2 (de) | 2005-09-29 |
Family
ID=20278889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60104825T Expired - Lifetime DE60104825T2 (de) | 2000-03-21 | 2001-03-21 | Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen |
Country Status (13)
Country | Link |
---|---|
US (1) | US6747156B2 (de) |
EP (1) | EP1265888B1 (de) |
JP (1) | JP4370073B2 (de) |
AT (1) | ATE273295T1 (de) |
AU (2) | AU2001244913B2 (de) |
CA (1) | CA2402748C (de) |
DE (1) | DE60104825T2 (de) |
ES (1) | ES2225507T3 (de) |
HK (1) | HK1051854B (de) |
PT (1) | PT1265888E (de) |
SE (1) | SE0000933D0 (de) |
TR (1) | TR200402787T4 (de) |
WO (1) | WO2001070730A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005232129A (ja) * | 2004-02-23 | 2005-09-02 | Air Water Chemical Inc | 芳香族性アセチレン類の製造方法 |
US9492400B2 (en) | 2004-11-04 | 2016-11-15 | Massachusetts Institute Of Technology | Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals |
WO2007070682A2 (en) | 2005-12-15 | 2007-06-21 | Massachusetts Institute Of Technology | System for screening particles |
JP2009534309A (ja) | 2006-03-31 | 2009-09-24 | マサチューセッツ インスティテュート オブ テクノロジー | 治療剤の標的化送達のためのシステム |
JP5630998B2 (ja) | 2006-05-15 | 2014-11-26 | マサチューセッツ インスティテュート オブ テクノロジー | 機能的粒子のためのポリマー |
WO2007150030A2 (en) * | 2006-06-23 | 2007-12-27 | Massachusetts Institute Of Technology | Microfluidic synthesis of organic nanoparticles |
WO2008019142A2 (en) * | 2006-08-04 | 2008-02-14 | Massachusetts Institute Of Technology | Oligonucleotide systems for targeted intracellular delivery |
WO2008124632A1 (en) * | 2007-04-04 | 2008-10-16 | Massachusetts Institute Of Technology | Amphiphilic compound assisted nanoparticles for targeted delivery |
AU2008314647B2 (en) | 2007-10-12 | 2013-03-21 | Massachusetts Institute Of Technology | Vaccine nanotechnology |
US8343498B2 (en) | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
US8277812B2 (en) | 2008-10-12 | 2012-10-02 | Massachusetts Institute Of Technology | Immunonanotherapeutics that provide IgG humoral response without T-cell antigen |
US8591905B2 (en) | 2008-10-12 | 2013-11-26 | The Brigham And Women's Hospital, Inc. | Nicotine immunonanotherapeutics |
US8343497B2 (en) | 2008-10-12 | 2013-01-01 | The Brigham And Women's Hospital, Inc. | Targeting of antigen presenting cells with immunonanotherapeutics |
EP2575773A4 (de) | 2010-05-26 | 2014-06-25 | Selecta Biosciences Inc | Synthetische nanoträgerkombinationsimpfstoffe |
AU2014210682B2 (en) * | 2010-06-04 | 2015-10-08 | Pfizer Vaccines Llc | Conjugates for the prevention or treatment of nicotine addiction |
TWI578997B (zh) | 2010-06-04 | 2017-04-21 | 輝瑞疫苗有限責任公司 | 用於預防或治療菸鹼成癮之共軛體 |
EA201390660A1 (ru) | 2010-11-05 | 2013-11-29 | Селекта Байосайенсиз, Инк. | Модифицированные никотиновые соединения и связанные способы |
CN103702687A (zh) | 2011-07-29 | 2014-04-02 | 西莱克塔生物科技公司 | 产生体液和细胞毒性t淋巴细胞(ctl)免疫应答的合成纳米载体 |
US9303013B2 (en) | 2014-05-16 | 2016-04-05 | Pfizer Inc. | Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4155909A (en) * | 1977-06-13 | 1979-05-22 | Philip Morris Incorporated | 2-Alkyl nicotinoids and processes for their production |
US4465833A (en) * | 1980-10-15 | 1984-08-14 | Hughes Aircraft Company | Process for preparing ethynylated benzoic acid derivatives |
DE4020053A1 (de) * | 1990-01-31 | 1991-08-01 | Bayer Ag | Verfahren zur herstellung von 2-chlor-5-methyl-pyridin |
DE4020052A1 (de) * | 1990-06-23 | 1992-01-02 | Bayer Ag | Verfahren zur herstellung von 2-chlor-5-methyl-pyridin |
US5502194A (en) * | 1992-02-19 | 1996-03-26 | Bayer Aktiengesellschaft | Process for the preparation of 2-halogeno-pyridine derivatives |
KR100309871B1 (ko) | 1999-02-24 | 2001-10-29 | 윤종용 | (-)피리도벤즈옥사진 카르복실산 유도체의 제조방법 |
SE9801923D0 (sv) * | 1998-05-29 | 1998-05-29 | Independent Pharmaceutical Ab | Nicotine vaccine |
US20040079259A1 (en) | 2002-10-29 | 2004-04-29 | Felix Manig | Method of manufacturing cementitious materials |
FR2849657B1 (fr) | 2003-01-03 | 2005-07-15 | Arjo Wiggins | Feuille possedant un aspect iridescent, et son procede de fabrication |
-
2000
- 2000-03-21 SE SE0000933A patent/SE0000933D0/xx unknown
-
2001
- 2001-03-21 TR TR2004/02787T patent/TR200402787T4/xx unknown
- 2001-03-21 AU AU2001244913A patent/AU2001244913B2/en not_active Ceased
- 2001-03-21 WO PCT/SE2001/000599 patent/WO2001070730A1/en active IP Right Grant
- 2001-03-21 JP JP2001568933A patent/JP4370073B2/ja not_active Expired - Fee Related
- 2001-03-21 US US10/221,175 patent/US6747156B2/en not_active Expired - Fee Related
- 2001-03-21 PT PT01918042T patent/PT1265888E/pt unknown
- 2001-03-21 CA CA2402748A patent/CA2402748C/en not_active Expired - Fee Related
- 2001-03-21 EP EP01918042A patent/EP1265888B1/de not_active Expired - Lifetime
- 2001-03-21 ES ES01918042T patent/ES2225507T3/es not_active Expired - Lifetime
- 2001-03-21 AU AU4491301A patent/AU4491301A/xx active Pending
- 2001-03-21 AT AT01918042T patent/ATE273295T1/de active
- 2001-03-21 DE DE60104825T patent/DE60104825T2/de not_active Expired - Lifetime
-
2003
- 2003-02-28 HK HK03101515.1A patent/HK1051854B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2225507T3 (es) | 2005-03-16 |
HK1051854A1 (en) | 2003-08-22 |
JP4370073B2 (ja) | 2009-11-25 |
CA2402748C (en) | 2010-02-16 |
US6747156B2 (en) | 2004-06-08 |
HK1051854B (zh) | 2005-02-18 |
US20030187270A1 (en) | 2003-10-02 |
WO2001070730A1 (en) | 2001-09-27 |
EP1265888B1 (de) | 2004-08-11 |
SE0000933D0 (sv) | 2000-03-21 |
EP1265888A1 (de) | 2002-12-18 |
JP2003529568A (ja) | 2003-10-07 |
PT1265888E (pt) | 2004-11-30 |
CA2402748A1 (en) | 2001-09-27 |
DE60104825T2 (de) | 2005-09-29 |
AU4491301A (en) | 2001-10-03 |
TR200402787T4 (tr) | 2004-11-22 |
ATE273295T1 (de) | 2004-08-15 |
AU2001244913B2 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60104825D1 (de) | Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen | |
DE60336867D1 (de) | Verfahren zur Herstellung von 3-Halo-4,5-Dihydro-1H-Pyrazolen | |
DE60236600D1 (de) | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung | |
MXPA04001323A (es) | Dihidro-3-halo-1h-pirazol-5-carboxilatos sustituidos, su preparacion y uso. | |
MXPA03011039A (es) | Nuevos compuestos heterociclicos, su preparacion y uso como medicamentos, particularmente como agentes anti-bacterianos. | |
RS53398B (en) | PROCEDURE FOR OBTAINING AMINO CROTONYL UNITS | |
NO20062644L (no) | DPP-IV inhibitorer | |
DE69534029D1 (de) | Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung | |
TW200738667A (en) | Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof | |
CY1105666T1 (el) | Διεργασια για την παρασκευη αζακυκλοαλκανοϋλαμινοθειαζολων | |
DE60326819D1 (de) | Verfahren zur herstellung von inhibitoren der hmg-coa-reduktase | |
ATE501120T1 (de) | Verfahren zur herstellung von isoindolderivaten | |
DE60001182D1 (de) | Erythromycin-Derivate, ihr Verfahren zur Herstellung und ihre Verwendung als Arzneimittel | |
DE69920708D1 (de) | Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion | |
DE60310609D1 (de) | Verfahren zur herstellung von 2-aminomethylpyridin-derivaten | |
DE60107292D1 (de) | Verfahren zur herstellung von (+)-trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
ATE280769T1 (de) | Verfahren zur herstellung von vitronectin- rezeptorantagonisten | |
ATE502030T1 (de) | Imidazolderivate, verfahren zu deren herstellung und deren verwendung | |
DE60103752D1 (de) | Verfahren zur herstellung von pyrazolopyridinderivaten | |
DE60335805D1 (de) | Verfahren zur herstellung von 1,3-dioxolan-nucleosiden | |
HUP0104045A2 (hu) | Eljárás 4-[(2',5'-diamino-6'-halogén-pirimidin-4'-il)-amino]-ciklopent-2-enilmetanol-származékok előállítására | |
DE60306361D1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
DE69818431D1 (de) | Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin | |
DE602004027401D1 (de) | Verfahren zur herstellung von polymorphen von sertralin hydrochlorid | |
ATE253048T1 (de) | Verfahren zur herstellung von piperidincarbonsäureamiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |